Want to see IN:AJOONI full AI Analyst Report?
AJOONI Stock Chart & Stats
₹5.13
₹0.07(0.90%)
At close: 4:00 PM EST
₹5.13
₹0.07(0.90%)
Day’s Range― - ―
52-Week Range₹2.68 - ₹5.50
Previous CloseN/A
Volume422.93K
Average Volume (3M)291.27K
Market Cap
₹502.95M
Enterprise Value₹897.51M
Total Cash (Recent Filing)₹3.74M
Total Debt (Recent Filing)₹269.11M
Price to Earnings (P/E)12.8
Beta1.11
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding172,243,590
10 Day Avg. Volume221,455
30 Day Avg. Volume291,271
Financial Highlights & Ratios
PEG Ratio-0.85
Price to Book (P/B)2.02
Price to Sales (P/S)1.01
P/FCF Ratio-7.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthRapid FY2026 revenue growth, following gains in earlier years, indicates that the company is expanding sales across its animal health and nutrition offering. If sustained, greater scale can strengthen distribution reach, support operating leverage, and create a larger base for future earnings growth.
Conservative Balance SheetLow debt relative to equity gives Ajooni Biotech greater financial flexibility than a highly leveraged business. This supports continued investment in products and distribution while reducing the pressure of interest obligations, although the recent increase in debt still requires monitoring.
Established Animal-Care Business ModelAjooni Biotech operates in the recurring animal health and nutrition value chain, serving livestock and poultry management needs through marketed products. This provides a clear commercial focus and positions the company to participate in ongoing farm and animal husbandry activity rather than relying on a single transaction.
Bears Say
Persistent Cash BurnFour consecutive years of negative operating cash flow show that reported earnings have not consistently converted into cash. Deepening free-cash-flow deficits can increase reliance on external funding, constrain reinvestment, and make execution more vulnerable if working-capital or investment needs remain elevated.
Thin And Softening MarginsLow and declining operating margins leave limited protection against cost increases or weaker product mix. Margin volatility also reduces confidence in the durability of earnings growth, because additional revenue may not translate into proportionate profit or internally generated cash.
Rising Leverage DirectionThe increase in debt points to a less favorable leverage trajectory even though the absolute debt-to-equity ratio remains conservative. Continued borrowing could gradually reduce financial flexibility and add repayment or interest burdens, especially while operating cash flow remains negative.
Ajooni Biotech Limited News
AJOONI FAQ
What was Ajooni Biotech Limited’s price range in the past 12 months?
Ajooni Biotech Limited lowest stock price was ₹2.68 and its highest was ₹5.50 in the past 12 months.
What is Ajooni Biotech Limited’s market cap?
Ajooni Biotech Limited’s market cap is ₹502.95M.
When is Ajooni Biotech Limited’s upcoming earnings report date?
Ajooni Biotech Limited’s upcoming earnings report date is Nov 06, 2026 which is in 13 days.
How were Ajooni Biotech Limited’s earnings last quarter?
Ajooni Biotech Limited released its earnings results on Aug 14, 2026. The company reported ₹0.025 earnings per share for the quarter.
Is Ajooni Biotech Limited overvalued?
According to Wall Street analysts Ajooni Biotech Limited’s price is currently Overvalued.
Does Ajooni Biotech Limited pay dividends?
Ajooni Biotech Limited does not currently pay dividends.
What is Ajooni Biotech Limited’s EPS estimate?
Ajooni Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ajooni Biotech Limited have?
Ajooni Biotech Limited has 172,243,590 shares outstanding.
What happened to Ajooni Biotech Limited’s price movement after its last earnings report?
Ajooni Biotech Limited reported an EPS of ₹0.025 in its last earnings report. Following the earnings report the stock price went up 2.387%.
Which hedge fund is a major shareholder of Ajooni Biotech Limited?
Currently, no hedge funds are holding shares in IN:AJOONI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ajooni Biotech Limited
Founded in 2010, Ajooni Biotech Limited is an Indian enterprise primarily engaged in the production and distribution of animal nutrition products. Headquartered in Mohali, India, the company's offerings encompass specialized cattle feeds and various dietary supplements for livestock.
Technical Analysis
Avanti Feeds Limited
―
M K Proteins Limited
―
Mukka Proteins Limited
―
Parag Milk Foods Ltd.
―
SKM Egg Products Export (India) Ltd.
―